Beta-blockers for the treatment of arrhythmias: Bisoprolol – a systematic review

•This is the first systematic review on the role of Bisoprolol, a lipophilic beta 1 selective receptor blocker, for the treatment of arrhythmias.•Bisoprolol is useful for the treatment of supraventricular arrhythmias, especially for rate control during atrial fibrillation.•Evidence also exists for its efficacy in the treatment of ventricular arrhythmias, both in primary and in secondary prevention.